Real-time enrollment status for this clostridioides difficile infection clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 1:42 PM UTC
| NCT Number | NCT07285213 |
| Recruiting Status | Recruiting |
| Condition | Clostridioides Difficile Infection |
| Phase | PHASE2 |
| Target Enrollment | 230 participants |
| Active Locations | 43 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | October 7, 2026 (5 days ago) |
As of October 12, 2026: Clinical trial NCT07285213 is currently recruiting participants. This phase2 study for clostridioides difficile infection is actively seeking new participants at 43 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07285213 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 43 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07285213 was last updated 5 days ago (October 7, 2026). HelloStudys verifies this status automatically.